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Abstract
Background: General Practitioners (GPs) play an important role in the follow-up of patients after deliberate
self-poisoning (DSP). The aim was to examine whether structured follow-up by GPs increased the content of,
adherence to, and satisfaction with treatment after discharge from emergency departments.
Methods: This was a multicentre, randomised trial with blinded assignment. Five emergency departments and
general practices in the catchment area participated. 202 patients discharged from emergency departments after
DSP were assigned. The intervention was structured follow-up by the GP over a 6-month period with a minimum
of five consultations, accompanied by written guidelines for the GPs with suggestions for motivating patients to
follow treatment, assessing personal problems and suicidal ideation, and availability in the case of suicidal crisis.
Outcome measures were data retrieved from the Register for the control and payment of reimbursements to
health service providers (KUHR) and by questionnaires mailed to patients and GPs. After 3 and 6 months, the
frequency and content of GP contact, and adherence to GP consultations and treatment in general were
registered. Satisfaction with general treatment received and with the GP was measured by the EUROPEP scale.
Results: Patients in the intervention group received significantly more consultations than the control group
(mean 6.7 vs. 4.5 (p = 0.004)). The intervention group was significantly more satisfied with the time their GP took
to listen to their personal problems (93.1 % vs. 59.4 % (p = 0.002)) and with the fact that the GP included them in
medical decisions (87.5 % vs. 54. 8 % (p = 0.009)). The intervention group was significantly more satisfied with the
treatment in general than the control group (79 % vs. 51 % (p = 0.026)).
Conclusions: Guidelines and structured, enhanced follow-up by the GP after the discharge of the DSP patient
increased the number of consultations and satisfaction with aftercare in general practice. Consistently with
previous research, there is still a need for interventional studies.
Trial registration: ClinicalTrials.gov Identifier: NCT01342809. Registered 18 April 2011.
Keywords: Adherence, Deliberate self-poisoning, General practitioner, Randomised trial, Satisfaction
Background
Deliberate self-harm (DSH) by poisoning and other
methods is a serious health problem worldwide. Repeated
DSH, morbidity and mortality are significantly increased
[1–3], and repetition rates among patients hospitalised for
DSH have been found to be 16 % the first year, with a
suicide rate of 7 % over the following nine years [4].
Suicide is one of the leading causes of death in the world,
occurring every 40 s [5]. Research is limited and the re-
sults are conflicting, and there is therefore insufficient em-
pirical evidence to provide adequate aftercare [6, 7].
Intervention studies involving telephoning patients [8],
sending postcards [9, 10], and different forms of psycho-
therapy have shown reductions in suicidal behaviour [11,
12]. In Norway, no effect was found for assertive outreach,
although with a non-randomised design, the results could
have been biased [13]. The model was replicated in two
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Danish trials; the first demonstrated decreased suicidal be-
haviour [14]. However, when replicated with a randomised
design and higher power, the findings were negative [15].
In these trials, it appears that continuity of care, availabil-
ity in times of crisis, and close contact with the patients at
risk were important elements in preventing further sui-
cidal behaviour [12, 10, 14, 16]. The role of the general
practitioner (GP), an already established and available
health care service in many countries, is consistent with
these elements. Further, the establishment of aftercare for
patients hospitalised for DSP is important, because many
receive no psychiatric follow-up, and report excessive
waiting time and the need for improved access to aftercare
[17]. Adherence to the planned treatment is also a prob-
lem [18]. The high proportion of suicidal patients who
make contact with GPs both before and after an episode
of DSH [17, 19, 20] and their diverse needs, underline the
fact that more research is needed on how best to manage
such patients in primary care. GPs can represent a stable
long-term contact and ensure a holistic approach by co-
ordinating and implementing additional services. In spite
of this, there have been a limited number of clinical trials
aiming to study follow-up in primary care and the poten-
tial of the GPs.
In a randomised controlled trial (RCT), the GPs re-
ceived guidelines and an invitation letter to be sent to
DSH patients after discharge from hospital [21]. This had
no effect on reducing repeated self-harm. However, the
question of whether the intervention would have had an
effect on outcome variables based on patients’ perceptions
remains. Patients’ evaluations of the treatment they re-
ceive from different health care services are relevant to
the development of high quality care. However, in a study
performed more than 25 years ago, outpatient counselling
was compared to aftercare in general practice. Here, there
were no significant differences between the groups regard-
ing whether they had found their treatment from GP or
out patient clinic helpful, or whether suicidal behaviour
decreased [22].
Based on the current status, a RCT was designed. The
intervention comprised a scheduled appointment with a
GP within 1 week of discharge and at least five scheduled
consultations over the next 6 months. The GPs received
guidelines with suggestions for assessing and managing
patients. Our aim was to examine whether this structured
intervention will be associated with a greater increase in
patient satisfaction and adherence to treatment provided
by a GP than treatment as usual.
Methods
A controlled clinical trial was performed at five hospitals in
Oslo and Akershus County, Norway. Oslo University Hos-
pital Ullevaal, Aker University Hospital, Diakonhjemmet
Hospital, Lovisenberg Hospital and Akershus University
Hospital.
Patients were randomised to intervention or treatment
as usual. Patients whose physicians refused to participate
were studied as a comparison group. The manuscript
reporting adheres to the CONSORT guidelines.
Inclusion criteria
DSP was defined in accordance with the WHO/EURO
Multicentre Study on Suicidal Behaviour [23], but in-
cluded only patients with poisoning.
The inclusion criteria were: aged 18–75, registered
with a GP, and discharged directly to home, thus enab-
ling follow-up by a GP.
Exclusion criteria
Excluded were patients with present psychosis, mental re-
tardation, organic cognitive impairment and those unable
to fill in the questionnaire because it was not written in
their native language.
Recruitment and participants
Prior to the trial, information and an invitation letter
were sent to all the registered GPs in the hospitals’
catchment areas. The patients were recruited from med-
ical departments after an episode of DSP. When a pa-
tient was ready for an interview in the hospital, usually
after the psychiatric assessment, he or she was informed
about the trial and invited to participate. The project co-
ordinator telephoned the GPs as soon as a patient was
assigned to intervention and explained the rationale of
the trial. Those who agreed to participate were sent in-
formation, guidelines, and a registration form. The GPs
in the control group were mailed a registration form and
a letter describing the trial in general and were asked to
treat the patients as usual.
Excluded were the GPs that either refused to partici-
pate beforehand or when approached by telephone and
asked about participation. Their patients were followed
in a comparison group.
Randomisation
Sealed envelopes with randomisation codes generated
from randomization.com were used. The codes were
stored separately at the hospital department secretary’s
office to ensure that no manipulation occurred after the
assignment to groups.
Blinding
The assignment personnel and the patients were sub-
jected to blinding at the time of inclusion in accordance
with Zelen randomisation [24] to ensure the conceal-
ment of allocation and thus control for selection bias.
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Because of the nature of the study, the patients were not
subjected to blinding during the study period.
Intervention
The intervention consisted of systematic follow-up for 6
months after discharge. The GP was instructed to contact
the patient and schedule an appointment as soon as pos-
sible, preferably within 1 week of discharge. Further, a
minimum of five consultations during the 6-month period
after discharge was recommended. GPs received written
guidelines with suggestions of topics to discuss with the
patient during the consultation. In addition, and where
possible, a discharge summary from the medical depart-
ment was sent to the GP immediately after discharge. See
Additional file 1.
Treatment as usual
The control and comparison groups received treatment
as usual. Arrangements of referrals to appropriate health
care services were based on the assessment by the psy-
chiatric liaison teams and the discharging physician in
the hospital.
Measures
At baseline in the hospital, the patients filled out a ques-
tionnaire with demographic background information on
their marital, living, educational and employment status,
and on previous DSH and psychiatric treatment. Ques-
tions from the European Parasuicide Study Interview
[25] were used to describe treatment in general practice
before and after the hospitalisation, and whether the pa-
tients communicated suicide ideation.
Three and six months after discharge from hospital,
the patients were mailed a questionnaire and at the same
time telephoned by the study team. Adherence to the
scheduled appointments with the GP was measured with
the question “Have you scheduled an appointment with
your GP but not kept it?” The number of dropouts was
measured with the question “To what extent have you
met your scheduled treatment appointments?”
Satisfaction with the GP was measured with the Norwe-
gian version of the European Task Force on Patient
Evaluations of General Practice (EUROPEP) [26]. The
questionnaire consists of a set of 25 items using a five-
point scale. Extremes are labelled as ‘1 = poor’ and ‘5 =
excellent’ on evaluations of different aspects of care: Com-
munication, the GP listening to patients, time spent in
consultations, and speed of response in cases of urgent
problems. See Additional file 2. Satisfaction with follow-
up in general was measured by the question “Overall, how
satisfied are you with the follow-up you have received?”
measured on a four-point Likert scale from 1 = very satis-
fied to 4 = very dissatisfied.
Additional information about health care services re-
ceived was also added to the questionnaire.
We sent registration forms to 171 GPs in the inter-
vention and control groups when their patients were
assigned to the trial. The overall response rate was
47 % (n = 87). There were 44 GPs in the intervention,
and 43 GPs in the control group who returned com-
pleted forms.
The variables in the registration form to the GPs were:
the number of consultations, telephone contact, whether
the patient had dropped out of appointments and been
provided with a rescheduled appointment, and whether
the GP had contacted the study team or others to dis-
cuss challenges related to the patient.
In addition, the intervention GPs reported the time
from hospital discharge until the first consultation and
the content of the consultations during the study
period.
Registry data
We retrieved data on all contact between the patients
and their GP during the 6-month period after discharge
from The Norwegian Register for the control and pay-
ment of reimbursements to health service providers
(KUHR). This register receives all refund applications
from the GPs. The data were recoded and categorised
into: Simple contact (without attending the GPs office),
normal consultation, extended consultation, consultation
with therapy or use of psychometric assessment tools or
other tasks related to psychiatric diagnoses, out-of-office
consultation, extended out-of-office consultation (mainly
somatic outpatient visits or home visits), talking to rela-
tives, filling out forms, and other contacts (sampling,
procedures, etc.).
The refund applications were also provided by ICPC-2
diagnoses related to each activity.
P (psychiatric), Z (social problems) and A-86 (poison-
ing) diagnoses were combined into the category psycho-
somatic, and all other diagnoses were categorised as
somatic.
Statistical power
Suicidal ideation was considered as the primary out-
come measure (this will be addressed in another paper).
A difference of 5 points on the Beck Scale for Suicidal
Ideation was considered to be clinically significant.
Assuming α = 0.05 and β = 0.2, and allowing for a one-
third dropout rate, the calculated sample size was 60
patients to each group.
Statistics
Descriptive statistics, means and frequencies were used.
Chi-square and Fisher’s exact tests were used to compare
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the categorical data. EUROPEP data were dichotomised
into item 1–3 (dissatisfied–neutral) and 4–5 (satisfied),
and chi-square tests used to compare all the items. The do
not applicable scores were replaced with missing. The
non-applicable scores were treated as missing data. The
comparisons of continuous variables were conducted by
means of independent sample t-tests. All statistical tests
were two-sided and p-values less than 0.05 were consid-
ered statistically significant. SPSS v.21 (Chicago, IL) was
used for statistical analyses.
Ethics
The Regional Ethics Committee, Region of Eastern
Norway, approved the study protocol for all the five
centres. Further the Personal Privacy Protection Agency
at Oslo University Hospital approved the study. The pa-
tients were informed verbally and signed a detailed
written consent in the hospital after recovery from the
acute poisoning. It was important to verify that regis-
tered patients were still alive before mailing them a
questionnaire. The participants were telephoned by a
health care professional in the study team at the time
they received the questionnaire and asked whether they
had questions related to it, or if they wished to provide
their answers by telephone. If the patients were severely
depressed or considered to have an ongoing suicidal
crisis, health care assistance was provided. During the
study period, the patients were given a telephone num-
ber to contact the project leader if they had any ques-
tions or wished to leave the trial.
We were not allowed to register personal security
:numbers to gather information about the patients who
did not meet the inclusion criteria or declined to partici-
pate. The Ethics Committee did not approve the proposed
use of a twofold written consent incorporating a request
for those who declined to participate in the trial to
complete a baseline questionnaire at the hospital.
Results
Sample and baseline characteristics
Among the 202 included patients, 101 were randomised
to intervention and 101 to the control group. Twenty-
six were excluded due to non-participation of their GP
(Fig. 1).
There were no significant differences between the
intervention group and the control group in terms of
baseline characteristics (Table 1). The majority were fe-
male. About 50 % had previously been hospitalised for
DSH. More than 50 % had received treatment in psychi-
atric care.
Dropout analyses showed no significant differences in
baseline characteristic variables between the partici-
pants and the patients that withdrew their consent dur-
ing follow-up. There were no significant differences in
baseline characteristics between the participants and
those not included.
Reason for consultation and communication of DSH
thoughts to GP before index episode
The vast majority of patients had consulted their GP in
the last year, and one-third of them had done so less
than 1 week before the episode (Table 2). There were no
differences between the study groups at baseline.
One-quarter of the patients had DSH thoughts during
the last consultation; and 50 % in the intervention group
and 57.1 % in the control group discussed their DSH
thoughts with their GP during the last consultation be-
fore the episode. The proportion of patients in both
groups that communicated suicidal thoughts to the GP
in the last month before the overdose in the current trial
was 54.8 % (35.5 % implied and 19.4 % told the GP
directly).
Thoughts of DSH and communication during the six
months follow up period
During follow-up, 40.9 % in the intervention group and
47.8 % in the control group had thoughts of DSH and
talked with their GP about them (p = 0.641). Of those
who had thoughts about DSH, 13 out of 31 (41.7 %) dis-
cussed them with the GP. In addition, 5 out of 12
(41.7 %) discussed thoughts about DSH even if they did
not report such feelings.
Contact with GP during the six-month post-discharge
period
Registry data from KUHR (Table 3) includes information
about contact and other activities performed by the GPs
during the six-month follow-up period. There was sig-
nificantly higher frequency of therapy and use of psycho-
metric assessment tools in the intervention group (mean
3.2 vs. 1.8, p = 0.037). The total number of consultations
was significantly higher in the intervention group (mean
6.7 vs. 4.5, p = 0.005). There was also a higher number of
activities registered with the ICPC-2 psychiatric, social
and poisoning diagnoses (mean 8.6 vs. 5.5 p = 0.007), as
shown in Table 4. During this period, 64 % in the inter-
vention group and 52 % in the control group had tele-
phone contact with their GP (p = 0.276). The mean time
from discharge to first consultation in the intervention
group was 7 days. (Data were not provided from the GPs
in the control group.)
Treatment as ususal
Apart from the significantly higher number of consulta-
tions with GPs in the intervention group, the treatment
received from different health care services did not differ
between the two groups. GP visits were most frequent,
followed by psychiatric outpatient clinic visits. Table 4
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displays the prevalence of received conversational therapy,
pharmacotherapy and treatment in psychiatric outpatient
clinics. There were no significant differences between the
study groups after 3 and 6 months.
There were no significant differences between the
study groups in patients reporting having received treat-
ment with psychotherapy, abuse related treatment, and
economical or family counselling.
During the trial, two GPs contacted the study team to
discuss problems related to a patient and one discussed
problems with another colleague.
Adherence
The dropout rate from the scheduled consultation re-
ported by the GPs was 34 % in the intervention group and
44 % in the control group (p = 0.593).
Eighty-six percent of the intervention group received a
new rescheduled appointment after dropout compared
with 67 % of the control group (p = 0.365).
The prevalence of patients reporting after 3 months
that they had not dropped out from planned treatment
was 83 % in the intervention group and 73 % in the con-
trol group (p = 0.086). After 6 months, these numbers
were 76 % and 73 %, respectively (p = 0.560).
Satisfaction
The scores on the EUROPEP scale after 6 months were
high in both groups, indicating a high degree of satisfac-
tion with all aspects of general practice (Fig. 2).
As shown in Fig. 2, the items 2–6 in the EUROPEP
scale related to the presence of a good doctor–patient
relation, with the items regarding the GP having interest,
making it easy to talk, and listening to problems being
higher in the intervention group than in the control
group. Those in the intervention group were signifi-
cantly more satisfied with the GP listening to personal
problems (93.1 % vs. 59.4 %, p = 0.002) and more of
them considered that the GP included them in medical
decisions (87.5 % vs. 54. 8 %, p = 0.009).
The satisfaction with treatment in general was also
high in both groups. After 3 months, the prevalence of
patients who were somewhat or highly satisfied was
Fig. 1 Consort flow chart
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83 % in the intervention group and 68 % in the control
group (p = 0.158). After 6 months, this difference was
significant (79 % vs. 51 % p = 0.026).
Discussion
Main findings
The main finding of this RCT of DSH patients after dis-
charge was that the prevalence of contact with the GP
related to psychosocial problems was significantly higher
in the intervention group. The patients were significantly
more satisfied with the treatment in general and re-
ported that the GPs listened to their personal problems
and involved them in decisions. The findings may con-
tribute to improved and more sustainable aftercare of
DSH patients.
Two important aspects related to suicidal behaviour in
general practice are availability in time of crisis, and re-
ferral to and follow-up of treatment from other health
care services, especially related to psychosocial prob-
lems. To achieve this, it is important that the GPs devote







GP consultations in last year before
DSH episode
No consultations 11.5 (7) 13.3 (11)
1–5 consultations 54.1 (33) 50.6 (42)
> 5 consultations 34.4 (21) 36.1 (30) 0.905
Last consultation before DSH
episode
< one week 31.7 (19) 24.7 (19)
1–4 weeks 38.3 (23) 45.5 (35)
> 4 weeks 30.0 (18) 29.9 (23) 0.607
Reason for last consultation
Somatic 41.7 (25) 46.9 (38)
Psychiatric 21.7 (13) 23.5 (19)
Both 36.7 (22) 29.6 (24) 0.676
DSH thoughts at last consultation
No 74.2 (46) 70.4 (57)
Yes 25.8 (16) 29.6 (24) 0.614
Talked with GP about DSH thoughts
in last consultation before DSH
episode
No 50 (8) 42.9 (9)
Yes 50 (8) 57.1 (12)a
Talked with GP but did not report
thoughts
1/46 2/57
aMissing n = 3
Table 1 Demographic and clinical characteristics
Intervention
group
(n = 62) % (n)
Control
group
(n = 87) % (n)
P value
Gender
Female 77.4 (48) 72.4 (63)
Male 22.6 (14) 27.6 (24) 0.490
Mean age (95 % CI) 35.6 (32–39) 40 (36–40) 0.081
Marital status
Single 50.0 (30) 40.5 (34)
Married/cohabiting 43.4 (26) 41.7 (35)
Separated/divorced 6.7 (4) 13.1 (11)
Widowed 0.0 (0) 3.6 (3) 0.312
Living status
Alone 37.7 (23) 39.7 (29)
With others 62.3 (35) 60.3 (48) 0.959
Education
Elementary high school 12.9 (8) 25.9 (22)
Secondary vocational 54.8 (34) 49.4 (42)
College/university 32.3 (20) 24.7 (21) 0.143
Employment status
Employed, student, military 49.2 (30) 40.5 (34)
Unemployed 14.8 (9) 13.1 (11)
Sick leave 6.6 (4) 11.9 (10)
Welfare recipient 23.0 (14) 13.1 (11)
Retired 0.0 (0) 7.1 (6)
Maternity leave 1.6 (1) 1.2 (1)
Other 4.9 (3) 13.1 (11) 0.103
Previously hospitalised for DSH
No 38.2 (21) 48.1 (37)
Yes 61.8 (34) 51.9 (40) 0.260
Previous psychiatric outpatient
treatment
No 44.3 (27) 45.1 (37)
Once 11.5 (7) 17.1 (14)
2–3 times 14.8 (9) 9.8 (8)
4 times or more 29.5 (18) 28.0 (23) 0.679
Previous psychiatric inpatient
treatment
No 59.0 (36) 69.9 (58)
Once 9.8 (6) 12.0 (10)
2–3 times 14.8 (9) 9.6 (8)
4 times or more 16.4 (10) 8.4 (7) 0.326
Want help to solve the problems
that triggered the current
episode
No 9.8 (6) 6.2 (5)
Yes 90.2 (55) 93.8 (76) 0.419
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sufficient time and are interested in the patients’ prob-
lems. The findings in this study indicate that these
premises were achieved.
The high degree of satisfaction with the care received
in general practice in both groups is important and un-
derlines the role of the GP in aftercare of DSH patients,
especially given the prevalence of patients that are re-
ferred to aftercare with their GP [20, 25].
This is supported by findings that most self-poisoning
patients considered their GP to be the most important
contact post-discharge [17]. Further, findings from an
English study indicated that DSH patients found it help-
ful and were satisfied when they discussed emotional
problems and factors that contributed to the act during
follow-up consultations with their GP [25].
Among those who had thoughts about DSH, 54.1 %
discussed them with the GP. In addition, 13.6 % dis-
cussed thoughts about DSH even if they did not report
experiencing such feelings. We do not know the reason
for this, but one possibility is that the GP raised the
question, perhaps because the patient seemed to be de-
pressed without having active DSH thoughts. These data
indicate that the GPs were aware of and motivated to
address suicidal issues before the study intervention.
Even so, it turned out to be possible for GPs to offer
more regular follow-up and address psychosocial issues
to a greater extent, which was also associated with more
satisfaction among the patients.
The prevalence of discussing suicidal ideation during
follow-up would ideally have been higher, especially in
the intervention group. It is possible, however, that the
climate for discussing such thoughts is strengthened if
the patients perceive that the GP has sufficient time and
shows an interest in psychosocial problems. Further, a
consistent and personal relationship with the GP as the
gatekeeper facilitates the communication of suicidal
ideation [27]. Further research should explore why pa-
tients in the intervention group did not communicate
suicidal thoughts to the GP, despite indicating that they
were more satisfied with the way the GP listened to their
personal problems.
Strengths and weaknesses
To our knowledge, this is the first time that the impact
of structured aftercare in general practice has been ex-
amined among DSH patients with satisfaction as one of
the outcomes. Further, the KUHR registry data increased
the reliability of the number of contacts made with GPs
and the specification of whether the contacts were re-
lated to psychosocial or somatic diagnoses. The use of
registry data also reduced answering bias, because the
response rate was lower than expected. These data also
enabled us to describe the extent and length of the con-
tact with GPs, which to our knowledge has not been in-
cluded in previous trials.
Another strength of this trial was the data provided by
several health care services on the type and place of
treatment for patients, thus enabling us to compare and
more clearly differentiate treatment given in the inter-
vention and the control groups. These comparisons have
not often been provided in similar RCT studies, but have
been requested in reviews [7, 28].
The trial was performed in wards in Oslo and Aker-
shus County, which are specialised in psychosocial as-
sessment and the referral of patients to appropriate
treatment after self-poisoning. The suicide motive was
assessed, which might have strengthened the inclusion
criteria in line with the definition of DSP.
The blinding at the time of assignment prevented bias
with regard to the usual treatment recommended in
follow-up plans. However the GPs were not blinded, and
therefore the comparison group with GPs that did not
wanted to participate emerged.
Table 3 Comparison of ICPC-2 diagnoses and contact with GP
during six-month post-discharge period
Intervention N = 62
Mean (SD)
Control N = 87
Mean (SD)
p value
ICPC-2 diagnoses reported from all GP contact
Somatic 4.0 (3.9) 3.6 (4.1) 0.605
Psychiatric, social, or
poisoning
8.6 (7.3) 5.5 (6.5) 0.007
Contact with GP
Consultationsa 6.7 (5.0) 4.5 (4.2) 0.005
All other patient-
related activitiesb
5.9 (6.1) 4.6 (5.4) 0.174
a Normal consultations and extra fees applied because of extended time spent
in consultations (over 20 min), therapy, and use of psychometric assessment
tools or other consultations related to psychiatric diagnoses
b Simple contact without attending GPs office, outside office consultations;
home visit or consultation in somatic outpatient clinic, talking with relatives,
contact with other services and all other patient-related activities










76.7 (23) 77.8 (35) 0.910
Pharmacotherapy 53.3 (16) 51.1 (23) 0.850
Psychiatric
outpatient clinic
48.4 (15) 57.1 (28) 0.444
3 to 6 months post-discharge
Conversational
therapy
71.4 (20) 58.8 (20) 0.302
Pharmacotherapy 57.1 (16) 38.2 (13) 0.138
Psychiatric
outpatient clinic
38.7 (12) 45.2 (19) 0.577
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The use of the validated EUROPEP scale also strength-
ened the reliability of the measured satisfaction with GPs.
Limitations
There are several limitations to the current study. First,
similar to Bennewith’s trial [21], we did not obtain informa-
tion from the GPs about whether they had actually used
the guideline. The patients’ retrospective self-report con-
taining information regarding their treatment and espe-
cially the communication of suicidal thoughts should also
have been verified by the form sent to the GPs. Further
studies should gather more detailed information about
how the intervention was carried out.
Nevertheless, the finding that a considerable number
of patients did not talk about their DSH thoughts indi-
cates that the guideline was not used consistently. On
the other hand, the GPs were encouraged to raise the
question of suicidal ideation, to invite the patients to
follow-up more actively and to address their compliance
with other treatment. This may have helped the GPs to
structure the consultations with these patients.
Second, the dropouts and self-reporting response rates
during follow-up biased the validity, although there were
no significant differences with regard to background vari-
ables at baseline. However, the socio-demographic profile
was similar to previous studies [14, 29] and strengthens
the external validity of the study.
The validity is also to some extent limited by the partici-
pation bias from the patients who declined to participate.
Although their number was lower than in similar studies,
the characteristics of the non-participants should prefera-
bly be described in future studies. However, this is difficult
in Norway because usually, Regional Ethics Committees
do not approve such studies. We did not obtain approval
from the Ethics Committee to describe demographic and
clinical factors in patients that did not consent to partici-
pate in the trial. In a Norwegian study of the same popula-
tion, although with a different design, the researchers
were allowed to obtain information about those who did
not participate. They found no significant difference
according to gender, but a higher age in the non-
participation group [30].
Third, the findings cannot be generalised as applying
to patients with higher risk of further suicidal behaviour,
such as patients admitted to psychiatric inpatient care
[29], those with no fixed abode [30], and DSH patients
using violent methods [31–33].
Fourth, the number of participants in the two groups
might have been more equal if we had adjusted for the
non-participating GPs, although this was difficult to esti-
mate beforehand.
Fifth, the GPs in the control group were not blinded.
This might have contributed to performing bias as they
could follow their patients more frequent than ususal. As
such, the results from the comparison group would there-
fore be more valid, because the GPs that declined to par-
ticipate in the pre-trial invitation were not informed again
when one of the patient on their list later was included in
the trial. However, the comparison group also consisted of
GPs that were telephoned during the trial when a patient
on their list was randomised into intervention and then
declined. Further it can be questioned whether it is ethic-
ally correct to blind the participating GPs in a RCT, and
therefore all the GPs in the current trial were given infor-
mation and an opportunity to consent.
Finally, factors that might influence the outcome are
not described. Attitudes and personal factors among the
GPs that may affect the doctor–patient relationship, how
the various problems are addressed, and whether the
patients feel that the GP endeavours to understand the
individual’s unique history and life circumstances, are all
important. Sensitivity to such factors and the ability to
handle interpersonally challenging encounters with pa-
tients may influence the outcome [34]. However, a com-
parison of satisfaction between the patients whose GP
declined participation and the control group yielded no
significant differences in satisfaction or prevalence of
Fig. 2 Satisfaction with general practitioner
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contact with the GP during the follow-up. Because all
the GPs in the intervention group agreed to participate,
it is difficult to specify the number of GPs in the control
group who declined because we only knew the number
of GPs who declined beforehand by responding nega-
tively to the pre-trial invitation. Given the premise that
the responding GPs were more inclined and dedicated
to the treatment of suicidal patients, an additional ana-
lysis of the GPs in both groups who returned the form
after 3 months was performed. No significant differences
between the control and the intervention group were
found in the outcome variables. However, the rather low
sample size in outcome variables from self-reporting in-
creases the risk of type 2 errors, whereas the outcomes
from the registry data did not show any differences.
Findings in relation to other studies
The finding of higher satisfaction in the intervention
group is consistent with results from trials in which pa-
tients received interpersonal therapy [12] and experi-
mental social work services [35]. In another RCT,
where Hawton and colleagues compared outpatient coun-
selling with aftercare in general practice, there were no
significant differences in repeated suicidal behaviour or
with regard to whether the patients perceived the treat-
ment as helpful [22].
Assertive outreach for poorly compliant patients may
be a necessary component in maximising the delivery of
any effective treatment [6]. In the present guidelines,
suggestions were made for GPs to encourage the patient
to follow planned treatment, although the dropout rates
did not differ between the intervention and control
groups. These findings are in contrast to previous trials
with community follow-up of patients who did not at-
tend outpatient appointments [18], and home treatment
where substantially increased rates of treatment take-up
were found [36].
Availability and assertive outreach after an episode of
DSH have shown promising results in decreasing sui-
cidal behaviour [37]. Diverging results were found in
two trials of assertive outreach in Denmark; one quasi-
experimental study showed a significant reduction in
repeated suicidal acts [14], while the replicated rando-
mised trial did not support these results [15]. These
trials were based on the Baerum model from Norway,
where suicide prevention teams followed patients after
discharge from hospitals. However, no significant decline
in repeated suicide attempts was found [13].
Bennewith and colleagues were moreover unable to
demonstrate any reduction in repeated DSH in one British
RCT in general practice, in which they sent a guideline to
the GPs [21]. This may indicate that even though it is pos-
sible to improve follow-up from GPs, interventions that
are more extensive may be necessary to reduce DSH.
Results from the current trial where outcome measures
are of suicidal symptoms and behaviour will be reported
in another paper.
Clinical implications
The findings related to increased contact with GPs are
consistent with one RCT [16] in which the researchers
pointed out that their intervention was useful for pa-
tients who had never received psychiatric care before
their index suicide attempt, and before they were offered
contact with health professionals.
Patients that are not already in a treatment programme
can be followed by their GP until they receive other
scheduled treatment. Improvement is needed, as many pa-
tients do not receive follow-up [38, 39]. Active outreach is
also important, because almost a third of patients did not
report follow-up despite arrangements registered at the
hospital [17]. More coordinated and frequent follow-up by
the GP could probably reduce this gap in the chain of
care. It is important that the hospital aims for a medical
review to be sent as soon as possible after discharge,
which has been an area in need of improvement [40].
In a study of self-poisoned patients, the waiting time
for a follow-up appointment, for example at psychiatric
outpatient units, was up to 3 weeks [17]. This is too long
for patients in crisis and can be compensated for by con-
sultations with the GP.
The average time from discharge to the first consult-
ation in the intervention group in the current trial was
7 days. This is an advantage when accounting for the
elevated risk of suicidal behaviour the first week after
discharge [41].
There was a significant higher frequency of ICPC-2
diagnoses of psychiatric, social, or poisoning in the inter-
vention group. The reason for this is not known. One
possible explanation could be that these diagnoses were
coupled to the planned consultations as part of the
intervention. Another possible cause may be be, that the
GPs in the intervention group were more aware and
thoroughly in their assessments of psychosocial prob-
lems among their patients.
Future research
The need for clinical trials in suicide prevention is
highlighted by the WHO’s Mental Health Action Plan
2013–20, where the Member States have committed to
work towards reducing the rate of suicide in countries
by 10 % by 2020 [5].
The need to target secondary prevention measures in
the large group of hospitalised DSH patients should be
emphasised and accompanied by financial support for per-
forming and facilitating sufficiently powered multicentre
and international cooperation clinical research whereby
Grimholt et al. BMC Psychiatry  (2015) 15:245 Page 9 of 11
suicidal behaviour constitutes a primary outcome measure
in line with the trial by Fleichmann et al. [42].
The need to provide sufficient health care services for
this patient group frequently attending general practice is
clear, but more research is neccessary to give firm recom-
mendations. The multifaceted problems and high levels of
psychiatric and physical morbidity, social deprivation and
suicidal symptoms must be addressed, particularly to pre-
vent the burden on the patients, their partners, children
and other relatives. The reasons behind DSH are diverse,
and include crisis reactions, severe depression or psych-
osis; tailored interventions for subgroups may make it eas-
ier to show the effect of intervention.
Conclusion
Structured follow-up by GPs after an episode of DSP
was associated with patients having more contact with
their GP, and this increase was related to their psycho-
social problems. The patients were also more satisfied
with their general treatment and the way that the GPs
listened to their personal problems and involved them in
the decision making.
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